Common shares, series B convertible preferreds sold at $0.50 per unit
By Devika Patel
Knoxville, Tenn., Aug. 4 – Metabolix, Inc. said it will raise $25 million in a private placement of units.
The company will sell 50 million units of one common share and 1/1,000 of a series B convertible preferred share at $0.50 per unit.
Each preferred will automatically convert into 1,000 common shares, based on a conversion price of $0.25 per share, which is a 41.96% discount to the Aug. 1 closing share price of $0.43.
Investors include Jack W. Schuler, Oracle Investment Management, Inc. and Birchview Capital.
Proceeds will be used for development and commercialization of Iluvien and other working capital purposes.
Cambridge, Mass.-based Metabolix develops alternatives to petrochemical-based plastics, fuels and chemicals.
| Issuer: | Metabolix, Inc.
|
| Issue: | Units of one common share and 1/1,000 of a series B convertible preferred share
|
| Amount: | $25 million
|
| Units: | 50 million
|
| Price: | $0.50
|
| Conversion price: | $0.25
|
| Conversion ratio: | Into about 1,000 common shares (per preferred)
|
| Warrants: | No
|
| Investors: | Jack W. Schuler, Oracle Investment Management, Inc., Birchview Capital
|
| Settlement date: | Aug. 4
|
| Stock symbol: | Nasdaq: MBLX
|
| Stock price: | $0.43 at close Aug. 1
|
| Market capitalization: | $14 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
